Human umbilical cord blood stem cell transplantation for the treatment of chronic spinal cord injury: electrophysiological changes and long-term efficacy

This study investigates the safety and long-term effectiveness of human umbilical cord blood stem cell transplantation for treating chronic spinal cord injuries. Twenty-five patients with traumatic spinal cord injuries (occurring more than 6 months prior) received stem cell treatment via intravenous and intrathecal injections. The study found that patients experienced restoration of autonomic nerve functions and a reduction in the latent period of somatosensory evoked potentials. Importantly, no severe adverse reactions were observed following the stem cell transplantation. These findings suggest that human umbilical cord blood stem cell transplantation is a safe and potentially effective treatment option for individuals with traumatic spinal cord injuries.

• 1
  Autonomic nerve functions were restored in some patients after stem cell transplantation.
• 2
  The latent period of somatosensory evoked potentials was reduced, indicating improved nerve conduction.
• 3
  No severe adverse reactions were observed in patients following stem cell transplantation, indicating safety.